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A B S T R A C T
Background: Reducing tuberculosis (TB) deaths among children requires a better understanding of the gaps in
the care cascade from TB diagnosis to treatment completion. We sought to assess the child TB care cascade in 32
rural communities in Uganda and Kenya using programmatic data.
Methods: This is a retrospective cohort study of 160,851 children (ages< 15 years) living in 12 rural commu-
nities in Kenya and 22 in Uganda. We reviewed national TB registries from health centers in and adjacent to the
32 communities, and we included all child TB cases recorded from January 1, 2013 to June 30, 2016. To
calculate the first step of the child TB care cascade, the number of children with active TB, we divided the
number of reported child TB diagnoses by the 2015 World Health Organization (WHO) child TB case detection
ratio for Africa of 27%. The remaining components of the Child TB Care Cascade were ascertained directly from
the TB registries and included: diagnosed with TB, started on TB treatment, and completed TB treatment.
Results: In two and a half years, a total of 42 TB cases were reported among children living in 32 rural com-
munities in Uganda and Kenya. 40% of the children were co-infected with HIV. Using the WHO child TB case
detection ratio, we calculated that 155 children in this cohort had TB during the study period. Of those 155
children, 42 were diagnosed and linked to TB care, 42 were started on treatment, and 31 completed treatment.
Among the 42 children who started TB treatment, reasons for treatment non-completion were loss to follow up
(7%), death (5%), and un-recorded reasons (5%). Overall, 20% (31/155) of children completed the child TB care
cascade.
Conclusion: In 32 rural communities in Uganda and Kenya, we estimate that 80% of children with TB fell off the
care cascade. Reducing morbidity and mortality from child TB requires strengthening of the child TB care
cascade from diagnosis through treatment completion.
1. Introduction
The World Health Organization (WHO) estimates that among chil-
dren worldwide there were one million incident cases of tuberculosis
(TB) and at least 210,000 TB deaths in 2015 [1]. Despite the high
burden of TB in children, it is estimated that at least two thirds of cases
in sub-Saharan Africa go un-diagnosed or un-reported [2]. Even when a
child is diagnosed with TB, treatment outcomes are often poor [3]. To
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reduce child TB deaths it is essential to strengthen the links in child TB
care from diagnosis through treatment completion.
The “Cascades of Care” framework is used widely in the HIV/AIDS
field to assess the quality of HIV care throughout the care continuum
[4]. This framework can be adapted for Child TB Care to describe the
sequential steps from TB diagnosis through linkage to TB care, treat-
ment initiation, and treatment completion. The care cascades model
defines one common outcome that all patients should achieve; for the
TB care cascade, that goal is the completion of TB treatment and
achieve a cure. To date there are no published studies that assess the
child TB care cascade in its entirety. The few studies that report on
components in the Child TB Care Cascade in sub Saharan Africa suggest
stark gaps in components of the cascade including failure to diagnose
TB [5–9] or complete treatment, [8–11] especially in children under the
age of five [5,8,9,12,13]. Applying the Childhood TB Care Cascade
framework to local data in the public domain can help identify where
children “fall off” the cascade and measure the efficacy of interventions
to increase the number of children who are cured of TB.
Our primary objective was to describe the Child TB Care Cascade in
32 rural communities in Uganda and Kenya from 2013 to 2016 using
local programmatic data from Uganda and Kenya national TB registers.
We also sought to identify subpopulations of children that may be
under diagnosed (i.e. children under five and children with smear ne-
gative disease) by applying the metrics of child TB diagnosis described
by Seddon et al. [14] These metrics can be applied to data from local
health centers, and deviations from the expected proportions can pro-
vide a snapshot of under- or over-diagnosis at the primary health care
center level.
2. Methods
2.1. Study design and participants
This is a retrospective observational cohort study of children ages
0–15 years of age who were enumerated in a census from 2012 to 2013
from 32 rural communities in Kenya and Uganda (12 communities in
Nyaanza province, Kenya, 10 in Eastern Uganda, 10 in Western
Uganda). We reviewed the national TB registers in each of the 32
communities to assess the number of reported TB cases, the TB case
characteristics, and to estimate the TB care cascade. We included cases
diagnosed between January 1, 2013 to June 30, 2016 to allow for full
documentation of 6 months of TB treatment by the time of database
closure on May 5, 2017.
2.2. Setting
This study is set in 32 rural communities in Uganda and Kenya that
were participating in the SEARCH HIV “test and treat” cluster-rando-
mized trial (NCT 01864503). The SEARCH trial design and community
selection have been previously described [15].
In these 32 rural communities, TB is primarily evaluated, diagnosed,
and treated in government-sponsored primary health centers. The
Kenyan and Ugandan national TB programs generally rely on passive
case finding. Patients present to primary health centers for evaluation
and, if diagnosed with TB, are referred to the National TB Program
where they are recorded in the TB treatment registry and offered
treatment. Primary health centers have access to sputum microscopy on
site. None of the primary health centers have access to mycobacterium
tuberculosis (MTB) culture or onsite radiographic service. Isoniazid
preventive therapy and active case finding are not widely implemented
in the 32 communities. Children with HIV receive HIV care at gov-
ernment-sponsored primary health centers and receive TB screening at
each clinical visit per national Ministry of Health protocols.
2.3. Variables and Definitions
2.3.1. Reported cases of child TB
We retrospectively reviewed national TB treatment registries from
health centers within and adjacent to the 32 study communities. We
defined a child TB case as a case if it was (a) documented in the national
TB registry as new, relapsed, or lost to follow up; (b) recorded in the
registry when the child was less than 15 years of age; and (c) matched
to a child enumerated in the SEARCH baseline census. TB cases from the
national TB registry were linked to SEARCH census by matching name,
sex, date of birth, and residence. We excluded cases from children
classified as “lost to follow up” and “relapsed” if they were already
included as a new case within our study period. The same methods were
used to define adult TB cases.
2.3.2. TB contact
We defined a child as having an adult TB contact if the child's
household identification number from the SEARCH study matched the
household identification number of an adult TB case from the national
TB registry.
2.3.3. Child TB case characteristics
National TB treatment registries include date, name, residence, sex,
type of tuberculosis (pulmonary or extrapulmonary), initial and follow
up smear results, treatment start date, and final treatment outcome. We
classified the site of TB disease as pulmonary if the sputum acid-fast
bacilli (AFB) smear was positive, even if concomitant extra-pulmonary
disease was present. Standard definitions of the Ugandan and Kenyan
National TB Program (NTP) were used to define TB treatment out-
comes: completed treatment, incomplete treatment- not taking anti-TB
drugs for two months or more after starting treatment, transferred out.
If a treatment outcome was not documented in the registry, then we
classified the outcome as treatment not completed.
2.3.4. HIV status
HIV status, CD4 count, and HIV viral load were obtained during the
ongoing community-wide SEARCH trial, which at baseline achieved
testing coverage in 89% adults [15] and 81% children [16] via a hybrid
mobile and community based HIV testing strategy. For this analysis, we
used the CD4 and viral load collected during the SEARCH trial's base-
line year in 2013–2014. We used the HIV status documented in the TB
registry for two children, as they were both missing a baseline HIV test
from the SEARCH trial. A child was defined as likely HIV-exposed un-
infected (HEU) if the child was HIV negative and the child's mother had
a positive HIV antibody test result during the baseline year of the
SEARCH study, 2013–2014. As part of the SEARCH study, we were able
to link all children under the age of 12 to the de-identified identification
number of their birth mothers. This identifier was then linked to the
mother's HIV status. A mother's HIV status was missing if the mother
was deceased at the time of the study, the mother did not live within the
child's household, or the mother declined HIV testing.
2.4. Assessing the child TB care cascade
The components of the Childhood TB Care cascade were adapted
from the HIV care cascade [4], and the measures of the cascade in-
cluded:
(1) Children with active TB: the estimated number of children with
active TB disease was defined as the number of child TB cases re-
ported in the study population divided by the case detection rate
(CDR) for Africa. We used the 2015 WHO child TB case detection
ratio (CDR) for Africa of 27%, as the CDR for child TB has not yet
been established for rural areas of East Africa. [17]. The 2015 WHO
Global TB Report reports that in Africa there were an estimated
330,000 cases of child TB, 90,523 of which were reported
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(CDR=27%). The global child TB CDR was 36%.
(2) Diagnosed with TB and linked to care: the number of children
diagnosed with TB (clinical or via smear) and who were registered
in the national TB Registry. We do not have information on people
who were diagnosed with TB, but who were lost to follow up prior
to linking to TB care.
(3) Started on TB treatment: the number of children who were di-
agnosed and linked to care that started TB treatment.
(4) Completed TB treatment: number of children who were started on
TB treatment and were recorded as completing TB therapy in the
government TB registers. Children who died, defaulted, or trans-
ferred out were defined as not completing TB treatment. We did not
have data on TB cure, so we used TB treatment completion as a
proxy for TB cure.
We combined data from Kenya and Uganda case into one cascade as
we did not detect statistically significant differences in the four com-
ponents of the cascade when stratified by country.
2.5. Measures of under-diagnosis or over-diagnosis of childhood TB
To assess over or under-diagnosis of childhood TB in subpopulations
of children we used the following indicators described in Seddon et al.
[14] and assumptions about child TB diagnosis: (1) expected proportion
of overall burden found in children: 15–20% [18] (2) expected pro-
portion of child TB cases that are smear positive: 10% (3) expected
proportion of child TB cases under the age of 5: 50% [18] (4) expected
proportion of cases of extra-pulmonary TB: 25% (<5 years) and 15%
(<15 years). These metrics can be applied to data from local health
centers and deviations from the expected proportions can provide a
snapshot of under- or over-diagnosis at the primary health care center
level.
2.6. Statistical analysis
Data was analyzed with STATA 12. We used the chi-squared and
Fisher exact test, where appropriate, to compare proportions.
Confidence intervals for point estimates were calculated using the
Fisher exact method.
3. Ethics
The Makerere University School of Medicine Research and Ethics
Committee (Uganda), the Ugandan National Council on Science and
Technology (Uganda), the Kenya Medical Research Institute Ethical
Review Committee (Kenya), and the University of California San
Francisco Committee on Human Research (USA) approved the consent
procedures and the SEARCH trial.
4. Results
160,851 children ages 0–15 years of age were enumerated in a
census from 2012 to 2013; 103,409 children from the 22 communities
in Uganda and 57,422 children from the 12 communities in Kenya.
From January 1, 2013 to June 30, 2016, a total of 42 child TB cases (27
cases in Kenya and 15 in Uganda) were reported among the children
enumerated in the census from the 32 communities.
4.1. Demographics of children diagnosed with TB
Demographic characteristics of the children in Kenya and Uganda
diagnosed with TB are described in Table 1. Among the children di-
agnosed active TB, 40% (17/42) were between the ages of 10 to 14
years, 19% (7/42) lived with an adult who was diagnosed with TB from
January 2013 to June 2016, and 40% (17/42) of the children were co-
infected with HIV. Among the 8 children with a viral load measure-
ment, 3 (38%) had a suppressed viral load (viral load≤ 500 copies/ml)
prior to being diagnosed with TB. Among the 37 children≤ 12 years
old, 57% (21/37) lived in a household with at least one HIV-infected
adult, 46% (17/37) had a mother infected with HIV, and 23% (6/37)
met our definition of a child who was likely HIV-exposed, but unin-
fected (HIV-infected mother, HIV-uninfected child).
4.2. Child TB case characteristics
TB case characteristics and treatment completion are described in
Table 1
Demographics of Children Diagnosed with Tuberculosis (TB) in 32 rural communities in
Uganda (N=15) and Kenya (N=27), January 1, 2013 to June 30, 2016.
n/N (%)
Gender
Female 27/42 (64%)
Age (years)
0–4 13/42 (31%)
5–9 12/42 (29%)
10–14 17/42 (40%)
Child living in a household with adult diagnosed with TBa 7/42 (19%)
Child's HIV status
HIV positive 17/42 (40%)
HIV negative 25/42 (60%)
Mother's HIV status
HIV-infected 17/37 (46%)
HIV-uninfected 13/37 (35%)
HIV status unknown 7/37 (19%)
HIV-exposed uninfected child
(HIV-infected mother, HIV-uninfected child) 6/37 (23%)
Child lives in household with HIV-infected adult 21/37 (57%)
Clinical characteristics of HIV-infected childrenb
On antiretroviral therapy prior to TB diagnosis 9/12 (75%)
On antiretroviral therapy before or after TB diagnosis 10/12 (83%)
HIV viral load< 500 copies/ml at baseline 3/8 (38%)
CD4+ count < 200 cells/ul 2/14 (14%)
Household characteristics
Median (IQR) number of household members 6 (5–9)
Wealth Index (tertiles)
1 (lowest) 6/37 (16%)
2 12/37 (49%)
3 (highest) 19/37 (51%)
a A child was defined as living with an adult diagnosed with TB if an adult in their
household was diagnosed with TB and entered in the registrar from January 1, 2013
through June 30, 2016.
b Excludes children missing data on antiretroviral therapy start and viral load.
Table 2
Case characteristics of children diagnosed with tuberculosis (TB) in 32 rural communities
in Kenya and Uganda (N=42), January 1, 2013–June 30, 2016.
Case type
New 37/42 (88%)
Relapse 4/32 (10%)
Default 1/42 (2%)
TB type
Pulmonary-smear positive 8/42 (19%)
Pulmonary-smear negative 10/42 (24%)
Pulmonary-smear not sent 4/42 (10%)
Extra-pulmonary 20/42 (48%)
TB type in children, age<5year
Pulmonary -smear positive 0%
Pulmonary -smear negative 3/13 (23%)
Pulmonary- smear not sent 2/13 (15%)
Extra-pulmonary 8/13 (62%)
2 month follow up smear completed (of those with positive
pre -treatment smear)
6/8 (75%)
Recorded treatment outcomes
Completed Treatment 31/42 (74%)
Did not complete treatment 3/42 (7%)
Died 2/42 (5%)
Transferred out 4/42 (10%)
Outcome unknown 2/42 (5%)
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Table 2. Among children diagnosed with TB, 52% (22/42) of children
had pulmonary TB and 48% (20/42) had extra-pulmonary TB. Children
under 5 made up 31% of the total child TB cases. Treatment outcomes
were as follows: 74% (31/42) of children completed TB treatment, 7%
(3/42) were documented to have not completed treatment, 5% (2/42)
died, 10% (4/42) were documented to have transferred out, and 5% (2/
42) did not have a documented treatment outcome. The 2 children who
died were both HIV-infected.
4.3. The childhood TB care cascade in 32 communities in Uganda and
Kenya
The childhood TB care cascade for our study communities in Kenya
and Uganda is presented in the Fig. 1. Using the WHO case detection
rate for child TB of 27%, [17] we calculated that there were 155 chil-
dren with TB disease in the 32 communities in Uganda and Kenya from
January 1, 2013- June 30, 2016. This number was obtained by dividing
the total number of reported child TB cases by the WHO child TB case
detection ratio (42/0.27). Of the 155 children calculated to have TB, 42
children were diagnosed and linked to care, and 42 were started
treatment. Of the 42 children started on treatment, 31 (70%) were
documented to have completed treatment. Thus, 20% (31/155) of
children with TB are estimated to have completed the childhood TB
care cascade.
4.4. Metrics of over and under diagnosis of child TB
The metrics of over- and under-diagnosis of childhood TB in the 32
communities in Kenya and Uganda are presented in Table 3. Childhood
TB accounted for 7% (95% CI: 5%−10%) of the TB burden in our 32
study communities: 5% (95% CI: 3%−8%) and 9% (95% CI: 6%−13%)
in Uganda and Kenya, respectively. In both Kenya and Uganda Indicator
1, the measured proportion of overall TB burden found in children, is
lower in both than the expected value of 15–20% [18] Indicator 2, the
measured proportion of smear positive cases (45% in Uganda and 27%
in Kenya), also exceeds the expected number of 10%. This suggests
clinicians may rely too heavily on smear microscopy and not enough on
clinical algorithms to make childhood TB diagnoses. In Kenya and
Uganda, indicators 2 and 4, the measured proportion of pediatric smear
positive TB and extra pulmonary diseases, exceed expected values,
which suggests under-diagnosis of smear negative disease and pul-
monary TB cases are missed.
5. Discussion
In this study of 32 rural communities in Kenya and Uganda, we used
programmatic data to assess the child TB care cascade. We found that a
fifth of children completed the TB care cascade. Our analysis of the
Seddon et al. [14] metrics of child TB diagnosis suggest that failure to
diagnose TB is a critical gap in the cascade. Even if children are diag-
nosed, the probability that they complete treatment is suboptimal. Only
70% of children who were diagnosed and linked to TB treatment
completed treatment, which falls short of the WHO's End TB goal of
90%. [19]. TB is a curable disease and these data highlight the need for
ongoing interventions to ensure that children do not fall off the TB care
cascade.
A critical failure in the child TB care cascade is the apparent under-
diagnoses of TB. In East Africa children are expected to comprise
15–20% of the total TB burden; [14,18] however, we found that chil-
dren made up only 5% and 9% of the total burden Uganda and Kenya
respectively. Other studies from community settings in sub-Saharan
Africa have also found a lower than expected proportion of TB cases in
children ranging from 6.3% in Nigeria [9], 7.5% in urban Uganda, [11]
and 13% in Southern Ethiopia [5]. The gap is particularly stark among
children under five. It is estimated that nearly 50% of child TB cases
should be among children under the age of five, as children under the
Fig. 1. The Childhood TB Care Cascade for 32 rural communities in Kenya and Uganda.
*The number of children with TB disease was calculated by dividing the number of recorded child TB cases (42) by the WHO case detection rate for Africa of 0.27 [17]. The number of
children diagnosed and linked to care, started on TB treatment, and completed TB treatment was extracted directly from the National TB Registries from the 32 communities in Kenya and
Uganda.
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age of five have the highest likelihood of progressing to active TB once
exposed [14,20]. However, as in other studies in East Africa, [5,7] we
found that the number of child TB cases among children under the age
of five (27% in Uganda and 33% in Kenya) fell short of the expected
number of 50%. Screening children who are in contact with TB is one
way to improve child TB case detection, [21] though this is rarely
implemented.
Improving a front-line clinician's ability to make TB diagnoses, in-
cluding clinical diagnoses, could help improve the child TB diagnosis
gap. In this study, over a quarter of pulmonary TB cases were smear
positive (45% in Uganda and 27% in Kenya), which is higher than the
expected value of 10%, [14,22,23] and suggests that not enough cases
are diagnosed clinically and an overreliance on smear to make a diag-
nosis. Our proportion of smear positive pulmonary disease is higher
than in a study from urban clinics in Uganda, where 15% of TB cases
were smear positive, [11] and a national study in Zambia where 6% of
child TB cases were smear positive [6]. Scaling up training on the use of
algorithmic diagnostic aids for Child TB, such as the Union's Pediatric
TB Desk [24] could improve knowledge gaps in child TB diagnosis.
Performance feedback on quality indicators has improved the quality of
adult TB care in rural health centers in Uganda [25] may also be helpful
for pediatric populations.
A central goal of the WHO End TB strategy is for 90% of children to
complete TB treatment [19]. In this study, 69% of children were
documented to have completed TB treatment. Data on child TB treat-
ment completion in rural areas East Africa is sparse, making compar-
isons challenging. However, our treatment completion rate is similar to
a study in Nyaanza province [13] that reported that 74% of children
with TB completed treatment, and a study from a rural district in
Ethiopia that reported that 82% of children completed TB treatment
[10]. TB is a curable disease and we should aim for 100% treatment
completion. Implementation of strategies for child friendly formula-
tions and innovative community and family-based care delivery models
might improve treatment completion rates.
We found a high burden of active TB among HIV-infected children.
This may be because HIV-infected children are more likely to be
screened for TB and because HIV-infected children are more vulnerable
to developing active disease once exposed to TB. ART decreases the
incidence of TB among HIV-infected children; [26,27] however, among
the children with a recorded viral load from 2013 to 2014, 55% (5/9)
had a detectable viral load. Preventing TB in this vulnerable group of
children will depend on improvements in ART adherence and im-
plementation of isoniazid preventive therapy.
HIV-exposed uninfected (HEU) children, a population growing at a
rate of 1 million annually, [28] may also be at high risk for TB disease.
This growing group of children have an increased risk of morbidity and
mortality, [29] and HIV-exposure has been associated with an increased
risk of latent TB infection in children under the age of 5 years [30]. In
this study, among children whose maternal HIV status was known, we
found that a fifth of the children with TB were likely HIV-exposed
uninfected children. Our data highlight the need to further quantify the
risk of TB infection among HEU children, a vulnerable group of children
who may need intensified TB screening and prevention efforts.
We also found that regardless of HIV status, the majority of children
with TB were connected to the HIV care system. Over half of children
lived with an HIV-infected adult and 45% had an HIV-infected mother.
Leveraging HIV-care delivery systems to improve TB diagnosis and TB
prevention among child TB contacts may be one way to strengthen the
child TB care cascade.
This study has important strengths and limitations. Our calculation
of the total number of child TB cases likely underestimates the true
number of child TB cases, as the WHO CDR for the African region is
likely higher than that in rural areas of East Africa where access to TB
diagnostics is limited. However, this is one of the first studies to adapt
the “care cascades” framework to child TB and provides an example of
how data in the public domain can be easily adapted to identify gaps in
a child TB care cascade. There are also limitations to applying the
Seddon et al. metrics of child TB diagnosis to our study. Firstly, the
expected values for metrics are not specific to our study population, as
these data are not available for rural areas of East Africa. Secondly, the
number of TB cases are small, which limits our power to detect dif-
ferences between expected and measured values. However, these me-
trics are intended to be provide a general snapshot of over and under
diagnosis and we have shown that they can be easily applied to local
data to identify potential areas for improvement.
In summary, to reveal local practice gaps in child TB care we ap-
plied the ‘cascades of care’ framework and metrics of child TB diagnosis
to programmatic data from 32 rural communities in Kenya and Uganda.
Less than a fifth of children made it through the child TB care cascade
and the biggest gap in the cascade was child TB diagnosis. Our analysis
Table 3
Programmatic indicators of how well childhood TB is diagnosed in 32 communities in rural Uganda and Kenya, indicators adapted from Seddon et al. [14].
Measured Expected
Uganda Kenya Approximate expected valuea Interpretation of the Comparison of Reported Value to
Expected Value
Indicator n/N % (95% CI) n/N % (95% CI) %
1. Proportion of overall burden
found in children
15/292 5% 27/297 9% 15–20%b Measured values under expected value. Suggests under
diagnosis of childhood TB.
(3%−8%) (6%−13%)
2. Proportion of pediatric
pulmonary TB cases that are
smear positive
5/11 45% 3/11 27% 10% Measured values over expected value. Suggests not
enough children treated for TB on clinical grounds in
Kenya
(17%−78%) (6%−61%)
3. Proportion of pediatric cases
aged< 5 years
4/15 27% 9/27 33% 50% Measured value under expected value. Suggests possible
under diagnosis of childhood TB among young children
(8%−55%) (17%−54%)
4.Proportion of pediatric cases that
are EPTB
4/15 27% 16/27 59% 10% in children< 15 years,
25% in children< 5 years
Measured value over expected value. Suggests possibility
of missed diagnoses of pulmonary TB and over diagnosis
of extra-pulmonary TB
(8%−55%) (39%−78%)
TB= tuberculosis, EPTB= extra-pulmonary TB.
a Expected values are adapted from those published in Seddon et al. [14] and provide a guide from which to compare measured values.
b Expected proportion of overall burden found in children adapted from Seddon et al. [14] and Dodd et al. [18].
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of the metrics of child TB diagnosis suggests that strengthening the
capacity of front-line clinicians to make clinical child TB diagnoses,
especially in children under that age of five, is one way to increase child
TB case detection in rural communities in East Africa. There is also
room for improvement in child TB treatment outcomes. Strategies to
improve diagnosis and child TB care delivery in rural areas of East
Africa are urgently needed to ensure that all children make it through
the TB care Cascade.
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